Evidence map›Paper›PMID 25484143›Full record

ArticleEpigenetics2014

Genome-wide DNA methylation analysis in precursor B-cells.

Md Almamun, Benjamin T Levinson, Susan T Gater, Robert D Schnabel, Gerald L Arthur, J Wade Davis, Kristen H Taylor

Open access · hybridAbstract read
In one paragraph

Article in Epigenetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Epigenetic Alterations in Inborn Errors of Immunity.Journal of clinical medicine · 2022
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer.Methods in molecular biology (Clifton, N.J.) · 2018
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Md Almamuna Department of Pathology and Anatomical Sciences ; University of Missouri-Columbia ; Columbia , MO USA.
Benjamin T Levinson
Susan T Gater
Robert D Schnabel
Gerald L Arthur
J Wade Davis
Kristen H Taylor
University of Missouri · USInstitute of Animal Sciences · CNTexas A&M University · US

Funding

Towards defining the functional methylome in acute lymphoblastic leukemiaR00CA132784 · NCI · UNIVERSITY OF MISSOURI-COLUMBIA · PI TAYLOR, KRISTEN H · 2011 to 2013
$694k
NCI NIH HHS R00 CA132784
6 · The paper itself

Abstract

DNA methylation is responsible for regulating gene expression and cellular differentiation and for maintaining genomic stability during normal human development. Furthermore, it plays a significant role in the regulation of hematopoiesis. In order to elucidate the influence of DNA methylation during B-cell development, genome-wide DNA methylation status of pro-B, pre-BI, pre-BII, and naïve-B-cells isolated from human umbilical cord blood was determined using the methylated CpG island recovery assay followed by next generation sequencing. On average, 182-200 million sequences were generated for each precursor B-cell subset in 10 biological replicates. An overall decrease in methylation was observed during the transition from pro-B to pre-BI, whereas no differential methylation was observed in the pre-BI to pre-BII transition or in the pre-BII to naïve B-cell transition. Most of the methylated regions were located within intergenic and intronic regions not present in a CpG island context. Putative novel enhancers were identified in these regions that were differentially methylated between pro-B and pre-BI cells. The genome-wide methylation profiles are publically available and may be used to gain a better understanding of the involvement of atypical DNA methylation in the pathogenesis of malignancies associated with precursor B-cells.

Indexed as

DNA MethylationCell DifferentiationCpG IslandsFetal BloodGenome-Wide Association StudyHigh-Throughput Nucleotide SequencingHumansInfant, NewbornLymphocyte SubsetsPrecursor Cell Lymphoblastic Leukemia-LymphomaPrecursor Cells, B-Lymphoidacute lymphoblastic leukemia; CpGCG dinucleotideCLP, common lymphoid progenitor cellscluster of differentiation; ALLCpGI, CpG islandDMRs, differentially methylated regionsDNA methylationenhancerFDR, false discovery rate.H3K27ac, histone H3 lysine 27 acetylationH3K4me1, histone H3 lysine 4 monomethylationHCB, human umbilical cord bloodHSCs, haematopoietic stem cellsMBDs, methyl CpG binding domainsMeCP2, methyl CpG binding protein 2MIRA-seq, methylated CpG island recovery assay (MIRA) followed by next generation sequencingnext-generation sequencingPre-B, precursor B-cell; CDprecursor B-cellPro-B, progenitor B-cellROIs, regions of interestTFs, transcription factorsumbilical cord blood

Identifiers

PMID25484143
PMCPMC4622941
OpenAlexW2083394556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.